F.No. 8(27)/00-DP/NPPA-Div.-II
National Pharmaceutical Pricing Authority
Ministry of Chemicals & Fertilizers
Government of India

2E/21, Jhandewalan Extn.,
New Delhi-110 055

Dated : 20th July, 2000

Explanatory Note

The National Pharmaceutical Pricing Authority has revised/fixed the prices of 61 formulation packs on July 20, 2000. Prices have been fixed for the first time in the case of 35 formulation packs, in the case of 23 packs the prices have been revised downwards on suo-motu basis and decrease ranges from 1.54% to 35.75%. The prices of three packs have been revised upward ranging between 5.5 % to 16.57%.

The ceiling prices (exclusive of excise duty and local taxes) have been fixed in respect of 42 formulation packs. The non-ceiling prices (inclusive of excise duty but exclusive of local taxes) have been fixed in respect of the 19 packs. The prices have been fixed/revised in accordance with the provisions of the Drugs Price Control Order (DPCO), 1995 and as per the established criteria and guidelines. A copy of the statement showing the existing (where applicable) and revised prices is enclosed herewith. The Notifications are available on the NPPA’s web-site www.nppaindia.com.

The formulations for which prices have been revised/fixed are Anti-tussives and anti-allergic formulations based on bulk drug Pseudoephedrine HCl in combination with other drugs, Streptomycin Injections used in the treatment of TB,, Griseofulvin based formulation used as Anti-fungal. Prices of Anti-biotic oral formulations based on bulk drug Erythromycin Streate, Erythromycin Estolate and Cloxacillin Sodium as single ingredient and in combination with bulk drug Ampicillin and Amoxycillin have also been revised downward.

The prices fixed/revised would become effective within 15 days from the receipt of the order of the NPPA in this behalf, as per Para 14(1) of DPCO, 1995. Necessary revised price list is to be issued by the manufacturers/importers required under sub paragraph (3) of paragraph 14 of the DPCO, 1995. Accordingly, as per the provision, the revised price list in Form-V of the DPCO is to be furnished by the concerned manufacturer to the government and NPPA, State Drug Control Authorities and distributors, wholesalers and retailers or any other agent.

The manufacturers are also required to work out the pro-rata prices of different pack sizes as the case may be in terms of S.O. No. 83(E) dated 27.01.98.

(L. M. Kaushal)
Deputy Director